Retroperitoneal Extragastrointestinal Stromal Tumors Have a Poor Survival Outcome: A Multicenter Observational Study
Weixian Hu,1,* Chengbin Zheng,1,* Renjie Li,2 Xingyu Feng,1 Guoliang Zheng,3 Zhichao Zheng,3 Wenjun Xiong,4 Guosheng Lin,5 Yongjian Zhou,5 Wei Wang,4 Yan Zhao,3 Yong Li1 1Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou...
Main Authors: | Hu W, Zheng C, Li R, Feng X, Zheng G, Zheng Z, Xiong W, Lin G, Zhou Y, Wang W, Zhao Y, Li Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/retroperitoneal-extragastrointestinal-stromal-tumors-have-a-poor-survi-peer-reviewed-article-CMAR |
Similar Items
-
Effect of the imatinib treatment regimen on the postoperative prognosis of patients with high-risk gastrointestinal stromal tumors
by: Li YS, et al.
Published: (2019-06-01) -
Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?
by: Tielen Ronald, et al.
Published: (2012-06-01) -
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
by: Sumin Tang, et al.
Published: (2017-04-01) -
Gastrointestinal stromal tumor and extragastrointestinal stromal tumor: Rare pattern of recurrence of disease
by: Amitabh Ray, et al.
Published: (2015-07-01) -
Extra-Gastrointestinal retroperitoneal giant stromal tumor complicated with intra-tumoral hemorrhage: case report and literature review
by: Suciu B.A., et al.
Published: (2015-02-01)